Anne Marie Cook's Net Worth

$2.67 Million

Estimate Recalculated May 3, 2024 07:02PM EST

Who is Anne Marie Cook?

Anne Marie Cook has an estimated net worth of $2.67 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC, VIACELL INC, Sage Therapeutics, Inc., and Aegerion Pharmaceuticals, Inc..

SEC CIK

Anne Marie Cook's CIK is 0001320559

Past Insider Trading and Trends

2019 was Anne Marie Cook's most active year for acquiring shares with 5 total transactions. Anne Marie Cook's most active month to acquire stocks was the month of January. 2019 was Anne Marie Cook's most active year for disposing of shares, totalling 4 transactions. Anne Marie Cook's most active month to dispose stocks was the month of April. 2019 saw Anne Marie Cook paying a total of $468,839.00 for 45,840 shares, this is the most they've acquired in one year. In 2019 Anne Marie Cook cashed out on 31,544 shares for a total of $2,628,304.72, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BIOGEN IDEC INC (BIIB) Snapshot price: $241.51

Acting General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found

VIACELL INC No price found

General Counsel, SVP

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 7
Form 4
—
0
—
—
0
Sep 21
Form 3
—
0
—
—
0
No matching records found

Sage Therapeutics, Inc. (SAGE) Snapshot price: $23.99

SVP, GC & Secretary

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+80.76%
11.25K
—
—
25.18K
Feb 13
Form 4
+25.95%
2.83K
$19.27
-$22,622.98
13.72K
Nov 28
Form 4
—
0
—
—
0
Feb 13
Form 4
+21.67%
1.87K
$44.16
-$43,276.80
10.5K
Feb 3
Form 4
—
0
—
—
0
Feb 11
Form 4
+51.52%
2.68K
$40.29
-$44,963.64
7.89K
Oct 19
Form 4
+134.91%
2.86K
$58.80
-$67,267.20
4.97K
Jun 15
Form 4
—
0
—
—
0
Feb 10
Form 4
—
0
—
—
0
Apr 28
Form 4
—
0
—
—
0
Feb 12
Form 4
+150.86%
1.06K
$161.38
-$136,204.72
1.76K
Jul 25
Form 4
—
0
—
—
0
Jun 21
Form 4
∞
700
$98.00
-$2,023,261.00
700
Scheduled
May 10
Form 4
—
0
—
—
0
Feb 13
Form 4
—
0
—
—
0
Dec 7
Form 4
—
0
—
—
0
Apr 2
Form 4
—
0
—
—
0
Feb 6
Form 4
—
0
—
—
0
Dec 8
Form 4
—
0
—
—
0
Feb 8
Form 4
—
0
—
—
0
Sep 16
Form 3
—
0
—
—
0
No matching records found

Aegerion Pharmaceuticals, Inc. No price found

SVP, General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found